Vaccine-associated poliomyelitis
Rosenthal, T.; Michaeli, D.
Harefuah 90(1): 25-26
1976
ISSN/ISBN: 0017-7768 PMID: 1248774 Document Number: 97294
Document emailed within 1 workday
Related Documents
Dane, D.S.; Dick, G.W.A.; Connolly, J.H.; Fisher, O.D.; McKeown, F.; Briggs, M.; Nelson, R.; Wilson, D. 1957: Vaccination Against Poliomyelitis with Live Virus Vaccines: 1. a Trial of TN Type Ii Vaccine. 2. a Trial of SM Type i Attenuated Poliomyelitis Virus Vaccine. 3. the Evaluation of TN and SM Virus Vaccines BMJ 1(5010): 59-74Sabin, A.B. 1982: Vaccine control of poliomyelitis in the 1980s Yale Journal of Biology and Medicine 55(3-4): 383-389
Hara, M. 1990: Serodiagnosis of poliomyelitis and prevention using an oral vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 348-351
Ermolovich, M.A.; Fel'dman, E.V.; Samoĭlovich, E.O.; Kuzovkova, N.A.; Levin, V.I. 2002: Characterization of the immune status of patients with vaccine-associated poliomyelitis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 42-50
John, T.J. 1984: Immune response of neonates to oral poliomyelitis vaccine British Medical Journal 289(6449): 881
Padayachee, N.; Hurwitz, H.S.; Vlok, A.; de Souza, C. 1990: Poliomyelitis vaccine coverage in south-western Johannesburg South African Medical Journal 77(3): 166-167
Dong, D.X.; Hu, X.M.; Liu, W.J.; Li, J.S.; Jin, Y.C.; Tan, S.G.; Chen, T.Q.; Fu, J.Z.; Niu, B.Y.; Yu, H.M. 1986: Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin) Bulletin of the World Health Organization 64(6): 853-860
Kaplan, A.S.; Vasilevskaia, N.I.; Kozhevnikov, I.N. 1978: Indicators of immunity in children vaccinated with live poliomyelitis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 115-117
Martin, J.F. 1985: Implications of the introduction of the new killed poliomyelitis vaccine into the expanded programme of immunization (EPI) Tropical and Geographical Medicine 37(3): S55-S59
Wiersbitzky, S. 1993: Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible? Kinderarztliche Praxis 61(3): 120-121
Francis, T.; Korns, R.F. 1955: Evaluation of 1954 field trial of poliomyelitis vaccine: synopsis of summary report American Journal of the Medical Sciences 229(6): 603-612
Lasch, E.E.; Abed, Y.; Marcus, O.; Gerichter, C.B.; Melnick, J.L. 1986: Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after Developments in Biological Standardization 65: 137-143
Prevots, D.R.; Strebel, P.M. 1997: Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine Pediatric Annals 26(6): 378-383
Gendon, I.Z. 1988: Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis Voprosy Virusologii 33(2): 137-141
Lim, F.Seng.; Han, H-Htay.; Jacquet, J-Marie.; Bock, H.L. 2007: Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine Annals of the Academy of Medicine Singapore 36(10): 801-806
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Prager, J.; Baumert, A.; Thilo, W.; Hermann, J.; Fuchs, D.; Sauerbrey, A.; Zintl, F. 1992: The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: the kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus Kinderarztliche Praxis 60(8): 230-238
De Silva, A.M.; Harris, E. 2018: Which Dengue Vaccine Approach Is the Most Promising, and Should we be Concerned about Enhanced Disease after Vaccination? the Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials Cold Spring Harbor Perspectives in Biology 10(6)
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452